Medical Advisory Board

Medical Advisory Board

Eliot Lazar, MD

Eliot Lazar, MD

Eliot Lazar, M.D. is a clinical ophthalmologist who serves as the President of El Con Medical Consulting, and the Principal of ElCon Medical in Buffalo, New York. Dr. Lazar has extensive experience in the commercial side of ophthalmology as well as other specialties. He has worked broadly in the development of devices, therapeutics and diagnostics, and has participated in many of the critical drug delivery advances in ophthalmology and other specialties. Dr. Lazar has also collaborated with financial Institutions of all sizes and scopes on both due diligence as well as at the BOD level. Dr. Lazar has worked collaboratively with both local and global organizations on endeavors ranging from pre-clinical through commercial stage. Dr. Lazar holds a BS from the University of Pennsylvania, an MS in Immunology from the Royal College of Surgeons at SUNY, and an MD from Georgetown University School of Medicine.

Edward Holland, MD

Edward Holland, MD

Edward Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. Dr. Holland has a national and international reputation for his knowledge and expertise in the field of cornea and external disease. Dr. Holland is the author of over 270 articles in peer review journals and has co-edited 4 editions of Cornea, the most widely read textbook on corneal disease and surgery. He attended the Loyola-Medical School in Chicago and trained in Ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa, and then a second fellowship in ocular immunology at the National Eye Institute. Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology and received both the Senior Achievement Award and Life Achievement Honor Award from the AAO. He also served as the President of American Society of Cataract and Refractive Surgery and presently serves as the Program Chair.

Richard Lindstrom, MD

Richard Lindstrom, MD

Richard L. Lindstrom is the Founder and attending surgeon at Minnesota Eye Consultants and an Adjunct Professor Emeritus at the University of Minnesota, Department of Ophthalmology. Dr. Lindstrom is a board-certified ophthalmologist and internationally-recognized leader in corneal, cataract, refractive and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon. After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr Lindstrom completed his doctorate degree in medicine in 1972. Dr. Lindstrom holds over 38 patents in ophthalmology and developed a number of solutions, intraocular lenses and instruments that are used in clinical practices globally. A frequent lecturer throughout the world on cornea, external diseases, cataract, refractive surgery, and glaucoma he has presented over 40 named lectures and keynote speeches before professional societies in the USA and abroad. He has co-edited ten books, published over 350 peer reviewed journal articles and 60 book chapters.

Jay Pepose, MD

Jay Pepose, MD

Jay S. Pepose M.D., Ph.D founded the Pepose Vision Institute and the Midwest Corneal Research Foundation, currently serving as its Medical Director. He is also a Professor of Clinical Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis. Dr. Pepose is a specialist in refractive surgery, corneal and external diseases. He is a consultant to the Centers for Disease Control and Prevention in Atlanta, Georgia. Dr. Pepose is actively involved in clinical research trials and has been the recipient of R-01 grant support from the National Eye Institute. Dr. Pepose is the Executive Editor of The American Journal of Ophthalmology and has served on the editorial board of numerous other prestigious journals, including IOVS, Cornea and The Journal of Refractive Surgery. Dr. Pepose has published over 160 peer reviewed articles and a book on ocular infections and inflammatory diseases. Dr. Pepose received an A.B. and M.A. in neurophysiology from Brandeis University, completed the MD-PhD program at the UCLA School of Medicine, his ophthalmology residency at the Wilmer Institute at The Johns Hopkins Medical Center and fellowship training at Georgetown University Medical Center.

David Boyer, MD

David Boyer, MD

David S. Boyer, MD is a Board-certified ophthalmologist specializing in treatment of diseases of the retina and vitreous and is senior partner at Retina-Vitreous Associates Medical Group with offices in Los Angeles, Beverly Hills, North Hollywood, Torrance, Pasadena and Tarzana, California. Dr. Boyer earned his medical degree at Chicago Medical School, completed his internship and residency at the University of Southern California/Los Angeles County Medical Center, and fellowship in retinal surgery at the Wills Eye Hospital in Philadelphia. Dr. Boyer, who is also Clinical Professor with the University of Southern California, has an extensive research background. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. A widely-published author and avid lecturer, Dr. Boyer lectures nationally and internationally on retinal research and the innovative approach to the treatment of retinal diseases. He has authored or co-authored numerous works in peer-reviewed journals, as well as served as a reviewer for ophthalmology and diabetes medical publications, including Archives of Ophthalmology, American Journal of Ophthalmology, and Ophthalmology.

Jack Holladay, MD, MSEE, FACS

Jack Holladay, MD, MSEE, FACS

Dr. Jack T. Holladay is a Board Certified Ophthalmologist, who received a Medical Degree and Distinguished Alumnus Award from the University of Texas and a Master’s and Bachelor’s Degree in Electrical Engineering from Southern Methodist University. He is a Clinical Professor of Ophthalmology at Baylor College of Medicine, the author of three books, hundreds of chapters and articles in peer-reviewed scientific journals and serves on several editorial, medical and scientific advisory boards as well as holding numerous patents. Dr. Holladay was inducted into the Hall of Fame of the American Society of Cataract and Refractive Surgery in 2012. He is currently the Chair of the FDA/AAO Task Force charged with developing guidelines for accommodating and extended depth of focus (EDOF) IOLs.

© Ocuphire Pharma, Inc. 2018 all rights reserved